Q3 EPS Estimates for Astera Labs Increased by Analyst

Astera Labs, Inc. (NASDAQ:ALAB) – Research analysts at Northland Securities lifted their Q3 2026 earnings estimates for shares of Astera Labs in a research report issued to clients and investors on Wednesday, August 5th. Northland Securities analyst G. Richard now expects that the company will earn $0.83 per share for the quarter, up from their previous forecast of $0.47. Northland Securities currently has a “Market Perform” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $1.86 per share. Northland Securities also issued estimates for Astera Labs’ Q4 2026 earnings at $1.09 EPS, FY2026 earnings at $2.75 EPS, Q1 2027 earnings at $1.13 EPS, Q2 2027 earnings at $1.32 EPS, Q3 2027 earnings at $1.44 EPS, Q4 2027 earnings at $1.55 EPS and FY2027 earnings at $5.43 EPS.

Other analysts also recently issued research reports about the company. Jefferies Financial Group upped their price target on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Evercore reissued an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Susquehanna boosted their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Citigroup reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $325.25.

Astera Labs Price Performance

Astera Labs stock opened at $311.99 on Wednesday. Astera Labs has a one year low of $97.89 and a one year high of $499.48. The company’s fifty day moving average price is $359.51 and its two-hundred day moving average price is $237.55. The company has a market capitalization of $54.13 billion, a price-to-earnings ratio of 154.45 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS.

Hedge Funds Weigh In On Astera Labs

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares during the last quarter. BlackRock Inc. bought a new position in shares of Astera Labs during the second quarter worth approximately $6,609,581,000. Atreides Management LP increased its stake in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the period. State Street Corp increased its position in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after buying an additional 104,935 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,256,894 shares of company stock valued at $362,763,135. Insiders own 10.40% of the company’s stock.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Northland Securities sharply raised its earnings forecasts. The firm increased its FY2026 EPS estimate to $2.75 from $1.82 and its FY2027 estimate to $5.43 from $2.26. Quarterly estimates were also lifted, including Q3 2026 EPS to $0.83 from $0.47 and Q4 2026 EPS to $1.09 from $0.56. The revisions imply stronger expected growth in Astera Labs’ AI connectivity business and are well above the current-year consensus estimate of $1.86 per share.
• Positive Sentiment: AMD’s Helios AI systems could benefit Astera Labs. Analysts expect AMD’s rack-scale AI systems to ramp, potentially creating additional demand for Astera Labs’ connectivity products alongside other ecosystem partners. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
• Neutral Sentiment: Northland maintained a “Market Perform” rating. Despite the major earnings-estimate increases, the unchanged rating suggests the analyst sees the improved outlook as largely reflected in the share price. Astera Labs recently reported revenue growth of 104.5% year over year and earnings above consensus, but its price-to-earnings ratio remains above 150.
• Neutral Sentiment: Reported short-interest data showed no meaningful positioning. The latest report listed short interest at zero shares and a zero-day short ratio, although the stated percentage change was unavailable, limiting its usefulness as a trading signal.
• Negative Sentiment: A director sold a substantial portion of his holdings. Stefan A. Dyckerhoff sold 12,499 shares for approximately $3.9 million, reducing his positions. The sales were made under a pre-arranged Rule 10b5-1 plan, which lessens—but does not eliminate—the potential bearish interpretation.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.